COVID-19 and Diabetes, Post-COVID Diabete

COVID-19 can exacerbate diabetes symptoms and increase the risk of severe outcomes. Post-COVID diabetes, a potential complication, may arise due to viral impact on pancreatic cells. Monitoring blood sugar levels, vaccination, and post-recovery diabetes screening are crucial to manage the interplay between COVID-19 and diabetes effectively.

    Related Conference of COVID-19 and Diabetes, Post-COVID Diabete

    July 29-30, 2025

    15th World Congress on Endocrinology and Diabetes

    Paris, France
    September 08-09, 2025

    3rd World congress and Expo on Diabetes

    Frankfurt, Germany
    October 27-28, 2025

    5th World Congress on Endocrine and Diabetes

    Madrid, Spain
    October 30-31, 2025

    5th Annual Summit on Diabetes and Endocrinology

    Paris, France
    November 03-04, 2025

    34th European Diabetes Congress

    Rome, Italy
    November 06-07, 2025

    8th Annual Meeting on Diabetes and Endocrinology

    Dubai, UAE
    November 20-21, 2025

    21st World Congress on Endocrinology & Diabetes

    Paris, France
    November 24-25, 2025

    6th International conference on Diabetic complications

    Barcelona, Spain
    February 23-24, 2026

    19th International Summit on Diabetes

    London, UK
    March 26-27, 2026

    7th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands
    May 18-19, 2026

    57th Annual Congress on Endocrinology and Diabetes Research

    Aix-en-Provence, France

    COVID-19 and Diabetes, Post-COVID Diabete Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in